作者:Sonja Merkas、Mladen Litvic、Ivica Cepanec、Vladimir Vinkovic
DOI:10.3390/10121429
日期:——
Novel representatives of the important group of biologically active dibenzosuberone derivatives were prepared: 3,7-dibromo-5-(dimethylaminoethyl- oxyimino)-10,11-dihydro-5H-dibenzo[a,d]cyclohepta-1,4-diene (1), 3,7-dibromo-5-(3- dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (2) and 1,7- dibromo-5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo-[a,d]-cycloheptene (3). These compounds are potential tricyclic antidepressants (TCAs), which are still the most frequently prescribed antidepressants in many countries.
制备出了具有重要生物活性的二苯并庚酮衍生物的新代表:3,7-dibromo-5-(dimethylaminoethyl- oxyimino)-10,11-dihydro-5H-dibenzo[a,d]cyclohepta-1,4-diene (1), 3,7-dibromo-5-(3- dimethylaminopropylidene)-10、3,7-二溴-5-(3-二甲基氨基亚丙基)-10,11-二氢-5H-二苯并[a,d]-环庚烯(2)和 1,7-二溴-5-(3-二甲基氨基亚丙基)-10,11-二氢-5H-二苯并[a,d]-环庚烯(3)。这些化合物是潜在的三环类抗抑郁药(TCAs),在许多国家仍是最常用的处方抗抑郁药。